Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Roger back buying
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2478)
•••
Comment by Eoganachton Sep 10, 2021 3:25pm
183 Views
Post# 33840965

RE:Roger back buying

RE:Roger back buyingSure does. Looks like he picked up another 45,000 shares today. He now has a total of 7,441,087 shares.

Filing Details
 
Issuer Name
Theralase Technologies Inc.
 
Insider Name
Dumoulin-White, Roger John
 
Relationship as filed with regulators
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
 
Transaction 
ID3801715
 
Filing Date
Sep 10, 2021
 
Transaction Date
Sep 10, 2021
 
Security Type
Common Shares
 
Transaction Nature
10 - Acquisition or disposition in the public market
 
Ownership Type
Direct Ownership
 
# or Value Acquired or Disposed of
45,000
 
Unit Price or Exercise Price
$0.220
 
Closing Balance
7,441,087


Oilminerdeluxe wrote: it appears


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities